Biofil Chemicals & Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Biofil Chemicals & Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Biofil Chemicals & Pharmaceuticals Ltd.

03 Jul 2025

46.55

0.41%

Company Update

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June, 2025

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

26 Jun 2025

46.55

0.41%

SAST

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Closure of Trading Window

BSE India

The Trading window for dealing in the securities of the Company shall remain closed for all Designated Persons, their immediate relatives and connected persons (as defined in the Code) w.e.f. Tuesday, July 01, 2025, for the purpose of consideration of Un-Audited Financial Results for the quarter ended June 30, 2025.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

12 Jun 2025

46.55

0.41%

Company Update

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Intimation To The Shareholders Holding Shares In Physical …

BSE India

The Company hereby submit drafts intimation letter sent to holders of physical shares of the company for updating PAN, KYC, Nomination and other details in accordance with applicable SEBI circulars in terms of provisions of Reg.30 of SEBI (LODR) Regulations, 2015 as amended from time to time.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

31 May 2025

46.55

0.41%

Company Update

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of Publication of Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

30 May 2025

46.55

0.41%

Result

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Audited Financial Result For The Financial Year Ended …

BSE India

Audited Financial Result for the Financial Year ended 31.03.2025

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

30 May 2025

46.55

0.41%

Board Meeting

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

Outcome of Board Meeting held on Friday 30th May, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

27 May 2025

46.55

0.41%

Company Update

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Submission of Annual Secretarial Compliance Report for the financial year ended 31st March 2025.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

22 May 2025

46.55

0.41%

Board Meeting

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Intimation for Intimation For Meeting Of …

BSE India

Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Intimation for meeting of Board of the Directors (Serial No.02/2025-26) of the Company scheduled to be held on Friday, 30th May, 2025 pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

22 Apr 2025

46.55

0.41%

Corp. Note

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Format of the Initial Disclosure to be made …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyBiofil Chemicals & Pharmaceuticals Ltd 2CIN NO.L24233MP1985PLC002709 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Apoorv Jain Designation: Company Secretary and Compliance Officer EmailId: bcplcompliance@gmail.com Name of the Chief Financial Officer: Pavan Singh Rajput Designation: Chief Financial Officer EmailId: pawan90rajkam@gmail.com Date: 22/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Biofil Chemicals & Pharmaceuticals Ltd.

19 Apr 2025

46.55

0.41%

Company Update

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement Under Regulation 30 (5) Of SEBI (LODR) …

BSE India

Appointment of Mr. Apoorv Jain ACS (71739) as Company Secretary and Compliance Officer of the Company.

pdf

Is Biofil Chemicals & Pharmaceuticals Ltd. worth buying?

81 Votes:

Buy 61.73%

Sell 24.69%

Hold 13.58%